A Plus Biotechnology Co., Ltd. (TPE:6918)

Market Cap	2.52B -28.0%
Revenue (ttm)	858.89M +9.0%
Net Income	173.26M +9.1%
EPS	5.12 -1.7%
Shares Out	34.07M
PE Ratio	14.47
Forward PE	n/a
Dividend	5.00 (6.74%)
Ex-Dividend Date	Mar 27, 2026

Volume	19,059
Open	73.10
Previous Close	74.20
Day's Range	73.00 - 74.20
52-Week Range	71.80 - 107.50
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About A Plus Biotechnology

A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of orthopedic and other medical devices. The company offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, biologics. It also provides bone grafts. A Plus Biotechnology Co., Ltd. was founded in 2009 and is based in New Taipei City, Taiwan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6918

Financial Performance

In 2025, A Plus Biotechnology's revenue was 835.89 million, an increase of 8.61% compared to the previous year's 769.59 million. Earnings were 169.38 million, an increase of 12.13%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 9, 2026

Data Sources Report a data error